PSEN1 and ovarian carcinoma: For this reason, the expression levels of miR-27-3p and PSEN-1 in ovarian cancer tissue samples will be further tested in the future, and whether miR-27-3p can upregulate ovarian cancer cells’ sensitivity to Olparib.